Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Post Market
Current status date:
2020-12-20
Original market date: See footnote 1
1987-12-31
Lot number: See footnote 2
142750
Expiry date: See footnote 2
2022-09-08
Product name:
UNIPHYL
DIN:
02014165
Product Monograph/Veterinary Labelling:
Date:
2020-09-30
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
ELVIUM LIFE SCIENCES
310
3381 Steeles Avenue East
Toronto
Ontario
Canada
M2H 3S7
Class:
Human
Dosage form(s):
Tablet (Extended-Release)
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
86:16.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
R03DA04 THEOPHYLLINE
Active ingredient group (AIG) number:See footnote5
0103582009
Active ingredient(s) | Strength |
---|---|
THEOPHYLLINE | 400 MG |